Bladder cancer: molecular determinants of personalized therapy.
Lopez-Beltran A, Santoni M, Massari F, Ciccarese C, Tortora G, Cheng L, Moch H, Scarpelli M, Reymundo C, Montironi R.
Lopez-Beltran A, et al. Among authors: massari f.
Curr Drug Targets. 2015;16(2):115-24. doi: 10.2174/1389450116666150204115756.
Curr Drug Targets. 2015.
PMID: 25654736
Review.